Therefore, the increase in brain insulin action may also apply to patients suffering from type 2 diabetes or neurodegenerative diseases like dementia who have a decreased insulin responsiveness and functional connectivity of the DMN (Albanese et al., 2017, Kullmann et al., 2016, Mohan et al., 2016). The gene discussed is INS; the disease is neurodegenerative disease.